Alert detail
LCD L38647: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer — Noridian
Policy ID: LCD-L38647Specialty: UrologyAdded: 6/5/2026Effective: 2026-04-16lcd
What changed
New MolDX may change bladder cancer billing practices.
Who’s affected: Urology billing teams · Effective: 2026-04-16
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
Subscribers get the recommended action (“what to do”), the full AI analysis, the LCD revision comparison, and related alerts across your specialty and jurisdiction.
Not ready to subscribe?
Get the free weekly reimbursement brief for Urology— the week’s changes and deadlines, delivered to your inbox. No account required.